Valuation: Gland Pharma Limited

Market Cap 466B 4.91B 4.39B 4.05B 3.67B 6.87B 6.98B 48.77B 19.31B 244B 18.44B 18.04B 770B P/E 2027 *
35.5x
P/E 2028 * 29.2x
Enterprise Value 430B 4.53B 4.04B 3.73B 3.38B 6.33B 6.44B 44.94B 17.79B 225B 16.99B 16.63B 710B EV / Sales 2027 *
5.71x
EV / Sales 2028 * 4.88x
Free-Float
48.26%
Yield 2027 *
0.72%
Yield 2028 * 0.79%
1 day-0.83%
1 week-7.81%
Current month-2.50%
1 month-3.08%
3 months+15.90%
6 months+56.99%
Current year+64.16%
1 week 2,769.8
Extreme 2769.8
3,075.1
1 month 2,769.8
Extreme 2769.8
3,171
Current year 1,573.6
Extreme 1573.6
3,171
1 year 1,573.6
Extreme 1573.6
3,171
3 years 1,277.8
Extreme 1277.8
3,171
5 years 861
Extreme 861
4,062.95
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,950 0.0012%
6/28/24 Sell 1,400 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-7.81%+47.04%+81.33% 4.96B
-2.54%+1.31%+55.10%+120.84% 1,165B
-1.42%+3.23%+37.07%+74.26% 645B
+0.16%+0.08%+25.14%+97.36% 504B
-0.31%+3.09%+43.92%+64.55% 380B
-1.34%-0.47%+66.63%+40.56% 363B
-0.68%+2.65%+22.46%+51.48% 297B
-1.20%+3.04%+2.62%+26.97% 269B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 195B
Average -0.68%+1.24%+37.92%+71.94% 406.04B
Weighted average by Cap. -0.25%+2.66%+41.08%+82.28%

Financials

2027 *2028 *
Net sales 75.26B 793M 708M 654M 593M 1.11B 1.13B 7.87B 3.12B 39.43B 2.98B 2.91B 124B 86.16B 908M 811M 749M 679M 1.27B 1.29B 9.01B 3.57B 45.14B 3.41B 3.33B 142B
Net income 13.22B 139M 124M 115M 104M 195M 198M 1.38B 547M 6.93B 523M 512M 21.84B 15.96B 168M 150M 139M 126M 235M 239M 1.67B 661M 8.36B 631M 618M 26.37B
Net Debt -36.59B -385M -344M -318M -288M -539M -548M -3.83B -1.52B -19.17B -1.45B -1.42B -60.45B -45.82B -483M -431M -398M -361M -675M -686M -4.79B -1.9B -24.01B -1.81B -1.77B -75.69B
Projected Income Statement - Annual - Gland Pharma Limited
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,332
Date Price Change Volume
26-10-23 ₹2,826.80 -0.83% 423,057
26-10-22 ₹2,850.40 -2.88% 338,424
26-10-21 ₹2,935.00 -2.81% 1,203,469
26-10-19 ₹3,019.80 -0.78% 167,122
26-10-16 ₹3,043.40 -0.75% 165,156
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Gland Pharma Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,826.80INR
Average target price
2,964.36INR
Spread / Average Target
+4.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Gland Pharma Limited
  1. Stock Market
  2. Stocks
  3. GLAND Stock